Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Metropolis Healthcare Ltd - 542650 - Board Meeting Outcome for Outcome Of Board Meeting Held On 24.05.2022

 This is to inform you that the Board of Directors of the Company at their meeting held today have inter-alia: 1. Approved the Standalone and Consolidated Financial Statements of the Company for the quarter and year ended March 31, 2022. The Audited Standalone and Consolidated Financial Statements of the Company as approved together with the Auditor's Report thereon for the quarter and year ended March 31, 2022 are enclosed as Annexure 1. Further, pursuant to the provisions of Regulation 33 (3) (d) of the SEBI LODR, the declaration of Unmodified Opinion by the Managing Director of the Company, in respect of the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2022 is enclosed as Annexure 2. 2. Re - appointment of B S R & Co. LLP, Chartered Accountants (ICAI Firm No. 101248W/W-100022) as Statutory Auditor of the Company for further term of 4 Years. The details pertaining to the Statutory Auditors is enclosed as Annexure 3.
24-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Outcome Of Board Meeting - Financial Results 31.03.2022

 This is to inform you that the Board of Directors of the Company at their meeting held today have inter-alia: 1. Approved the Standalone and Consolidated Financial Statements of the Company for the quarter and year ended March 31, 2022. The Audited Standalone and Consolidated Financial Statements of the Company as approved together with the Auditor's Report thereon for the quarter and year ended March 31, 2022 are enclosed as Annexure 1. Further, pursuant to the provisions of Regulation 33 (3) (d) of the SEBI LODR, the declaration of Unmodified Opinion by the Managing Director of the Company, in respect of the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2022 is enclosed as Annexure 2. 2. Re - appointment of B S R & Co. LLP, Chartered Accountants (ICAI Firm No. 101248W/W-100022) as Statutory Auditor of the Company for further term of 4 Years. The details pertaining to the Statutory Auditors is enclosed as Annexure 3.
24-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir/Madam, We would like to inform you that InCred Equities will host an earnings call on behalf of the Company with the analysts and investors at 09.00 AM (IST) on Wednesday, May 25, 2022 wherein the management of the Company will discuss the Q4FY22 Results and Future outlook as enclosed.
18-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Board Meeting Intimation for Intimation For Board Meeting Inter-Alia, To Consider And Approve The Audited Standalone & Consolidated Financial Results Of The Company For The Financial Year Ended March 31, 2022.

 Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company ('the Board') is scheduled to be held on Tuesday, May 24, 2022, inter-alia to consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the financial year ended March 31, 2022. We further wish to inform you that in terms of the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed with effect from April 1, 2022 and shall reopen 48 hours after the declaration of the financial results by the Company.
16-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Metropolis Healthcare Ltd 2 CIN NO. L73100MH2000PLC192798 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2021-22 , FY 2022-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Nil Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2020-21, FY 2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Simmi Singh BishtDesignation :-Head Legal and Secretarial Name of the Chief Financial Officer :- Rakesh Kumar Agarwal Designation : -Cheif Financial Officer Date: 14/05/2022
14-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company has on May 02, 2022, approved the allotment of 2,500 Equity Shares of Rs. 2/- each at an Exercise price of Rs.705.77/- per Equity Share aggregating to Rs.17,64,425/- to the eligible employees of the Company who have exercised their stock options pursuant to the Metropolis Employees Stock Option Scheme-2015 ("MESOS 2015"). Consequently, the paid-up Equity Share Capital of the Company shall stand increased from Rs. 10,23,44,494 consisting of 5,11,72,247 Equity Shares of Rs. 2/- each to Rs. 10,23,49,494 consisting of 5,11,74,747 Equity shares of Rs. 2/- each
02-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMetropolis Healthcare Ltd 2CINL73100MH2000PLC192798 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 258.33 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Simmi Singh Bisht Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Rakesh Kumar Agarwal Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2022

Metropolis Healthcare to set up 1,800 collection centres in three years

 The company is planning to add around 40 more Hitech centres during the current financial year
18-04-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 With reference to the captioned subject, we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company has on April 14, 2022, approved the allotment of 128 (One Hundred and Twenty-Eight) Equity Shares of Rs. 2/- (Rupees Two Only) each at an Exercise price of Rs.2/- (Rupees Two Only) per Equity Share aggregating to Rs. 256/- (Rupees Two Hundred and Fifty-Six Only) to the eligible employees of the Company who have exercised their stock units pursuant to the Metropolis - Restrictive Stock Unit Plan, 2020 ("MHL-RSU Plan 2020"). The said shares shall rank pari passu in all respects with the existing Equity shares of the Company. Consequent to the allotment of the aforesaid equity shares, the paid-up Equity Share Capital of the Company shall stand increased from Rs. 10,23,44,238/- consisting of 5,11,72,119 Equity Shares of Rs. 2/- each to Rs. 10,23,44,494/- consisting of 5,11,72,247 Equity shares of Rs. 2/- each.
14-04-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2022

 Pursuant to the requirements of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith the Compliance Certificate for the financial year ended March 31, 2022, duly signed by the Compliance Officer of Metropolis Healthcare Limited ('the Company') and the Authorized Representative of Link Intime India Private Limted, the Registrar and Share Transfer Agent of the Company
14-04-2022
Next Page
Close

Let's Open Free Demat Account